{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:33:35Z","timestamp":1787772815177,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Asymptomatic\/presymptomatic COVID-19 affected individuals who may appear healthy during blood donor screening can donate blood despite being infective. Most blood donors in India are relatives\/friends\/acquaintances of patients, who under peer pressure overlook the donor selection process, which can significantly impact the transfusion safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>AIMS:<\/jats:title>\n                    <jats:p>The prevalence of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) antibodies among blood donors was assessed, along with the possible transmissibility of SARS-CoV-2 virus in transfusion recipients of blood components prepared from sero-reactive blood donors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTINGS AND DESIGN:<\/jats:title>\n                    <jats:p>A prospective cross-sectional study was conducted among eligible blood donors from November-2020 to April 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>1500 blood donors were tested for SARS-CoV-2 IgG antibodies. Sero-reactive donors were followed-up telephonically to inquire about risk factors prior to donation or appearance of COVID-19 related symptoms postdonation. Patients transfused with blood components from seroreactive donors were also followed up for posttransfusion symptoms suggestive for COVID-19. Descriptive analysis was done for the donor and patient follow-up data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>A total of 452 (30.1%) donor were reactive, with median S\/CO ratio of 2.8 (interquartile range 1.5\u20135.5). Risk factors such as travel, contact, or quarantine were significantly higher among reactive donors. History of diabetes and\/or hypertension was associated with seroreactivity. Total 516 patients were transfused with blood components from these seroreactive donors. Three patients developed fever after transfusion, one of which was found to be PCR positive after 4 days of transfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Sero-reactivity rate among blood donors was lower than the general population. Optimum blood donor screening strategies can help decrease the possibility of blood collection from infected blood donors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ajts.ajts_9_22","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T04:48:23Z","timestamp":1664254103000},"page":"182-188","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology of severe acute respiratory syndrome-related coronavirus 2 antibodies in healthy blood donors and their follow-up"],"prefix":"10.4103","volume":"17","author":[{"given":"Rahul","family":"Chaurasia","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal Kumar","family":"Patidar","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hem Chandra","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suganya","family":"Palanisamy","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidushi","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Chopra","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Coshic","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"Anovel coronavirus from patients with pneumonia in China,","volume":"382","author":"Zhu","year":"2019","journal-title":"N Engl J Med"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"138919","DOI":"10.1016\/j.scitotenv.2020.138919","article-title":"COVID-19 faecal-oral transmission:Are we asking the right questions?","volume":"729","author":"Heller","year":"2020","journal-title":"Sci Total Environ"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.jiph.2020.05.001","article-title":"COVID-19 transmission and blood transfusion:A case report","volume":"13","author":"Cho","year":"2020","journal-title":"J Infect Public Health"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/trf.15841","article-title":"SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission","volume":"60","author":"Corman","year":"2020","journal-title":"Transfusion"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/22221751.2020.1729071","article-title":"Molecular and serological investigation of 2019-nCoV infected patients:Implication of multiple shedding routes","volume":"9","author":"Zhang","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3201\/eid2607.200839","article-title":"Severe acute respiratory syndrome coronavirus 2 RNA detected in blood donations","volume":"26","author":"Chang","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/vox.12925","article-title":"Post-donation COVID-19 identification in blood donors","volume":"115","author":"Kwon","year":"2020","journal-title":"Vox Sang"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/0973-6247.95047","article-title":"Family\/friend donors are not true voluntary donors","volume":"6","author":"Jain","year":"2012","journal-title":"Asian J Transfus Sci"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/0973-6247.164270","article-title":"Family donors are critical and legitimate in developing countries","volume":"10","author":"Allain","year":"2016","journal-title":"Asian J Transfus Sci"},{"issue":"10","key":"R14-20240830","first-page":"e19000","article-title":"Second Wave of the COVID-19 Pandemic in Delhi, India:High Seroprevalence Not a Deterrent?","volume":"13","author":"Sharma","year":"2021","journal-title":"Cureus"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tmrv.2021.07.003","article-title":"Progression and predictors of SARS-CoV-2 antibody seroreactivity in US blood donors","volume":"35","author":"Vassallo","year":"2021","journal-title":"Transfus Med Rev"},{"key":"R16-20240830","doi-asserted-by":"crossref","first-page":"853","DOI":"10.15537\/smj.2021.42.8.20210238","article-title":"Risk factors and predictors that influence SARS-Cov-2 IgG positivity:A cross-sectional study of blood donors in Riyadh, Saudi Arabia","volume":"42","author":"Alosaimi","year":"2021","journal-title":"Saudi Med J"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2021.07.001","article-title":"Characteristics of US blood donors testing reactive for antibodies to SARS-CoV-2 prior to the availability of authorized vaccines","volume":"35","author":"Dodd","year":"2021","journal-title":"Transfus Med Rev"},{"key":"R18-20240830","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/v13071225","article-title":"Seroprevalence of anti-SARS-CoV-2 antibodies in blood donors from Nuevo Leon state, Mexico, during 2020:A retrospective cross-sectional evaluation","volume":"13","author":"Martinez-Acu\u00f1a","year":"2021","journal-title":"Viruses"},{"key":"R19-20240830","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijid.2021.04.059","article-title":"Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors:The evolution of a pandemic","volume":"107","author":"Sughayer","year":"2021","journal-title":"Int J Infect Dis"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1017\/S0950268820001776","article-title":"COVID-19 in India:transmission dynamics, epidemiological characteristics, testing, recovery and effect of weather","volume":"148","author":"Chanda","year":"2020","journal-title":"Epidemiology and Infection."},{"key":"R21-20240830","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/trf.16320","article-title":"Pandemic blood donor demographics \u2013Do changes impact blood safety?","volume":"61","author":"Vassallo","year":"2021","journal-title":"Transfusion"},{"key":"R22-20240830","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/voxs.12383","article-title":"Effectiveness of predonation health and travel screening in reducing the risk of transfusion-transmitted infections","volume":"12","author":"Berg","year":"2017","journal-title":"ISBT Sci Ser"},{"key":"R23-20240830","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/trf.13106","article-title":"Failure of self-disclosure of deferrable risk behaviors associated with transfusion-transmissible infections in blood donors","volume":"55","author":"Wong","year":"2015","journal-title":"Transfusion"},{"key":"R24-20240830","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/tme.12747","article-title":"Role of donor self-reporting in securing blood safety during COVID-19 pandemic","volume":"31","author":"Ng","year":"2021","journal-title":"Transfus Med"},{"key":"R26-20240830","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"R27-20240830","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"R28-20240830","doi-asserted-by":"crossref","first-page":"e0253977","DOI":"10.1371\/journal.pone.0253977","article-title":"Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection","volume":"16","author":"Marchi","year":"2021","journal-title":"PLoS One"},{"key":"R29-20240830","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijid.2020.09.1484","article-title":"Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh","volume":"101","author":"Shirin","year":"2020","journal-title":"Int J Infect Dis"},{"key":"R30-20240830","doi-asserted-by":"crossref","first-page":"100734","DOI":"10.1016\/j.eclinm.2021.100734","article-title":"Antibody titers against SARS-CoV-2 decline, but do not disappear for several months","volume":"32","author":"Yamayoshi","year":"2021","journal-title":"EClinicalMedicine"},{"key":"R31-20240830","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.htct.2021.08.001","article-title":"SARS-COV-2:Is it a risk for blood transfusion?","volume":"44","author":"Langhi","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"key":"R32-20240830","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood.2020008230","article-title":"No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation","volume":"136","author":"Cappy","year":"2020","journal-title":"Blood"},{"key":"R33-20240830","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/tme.12724","article-title":"Absence of SARS-CoV-2 viraemia in a blood donor with COVID-19 post-donation","volume":"31","author":"Lee","year":"2021","journal-title":"Transfus Med"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_9_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:13:25Z","timestamp":1787771605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_9_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_9_22","relation":{},"ISSN":["0973-6247","1998-3565"],"issn-type":[{"value":"0973-6247","type":"print"},{"value":"1998-3565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"assertion":[{"value":"2022-01-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}